Welcome to our dedicated page for Markel Corporation SEC filings (Ticker: MKL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Markel Group Inc. (NYSE: MKL) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures, including current reports, periodic reports, and other documents filed with the U.S. Securities and Exchange Commission. As a diversified group built around specialty insurance, industrial, financial, and consumer businesses, Markel Group uses its filings to present segment results, capital allocation, and key changes in financial reporting.
Among the filings, investors can find current reports on Form 8-K that announce material events, such as the release of quarterly and nine-month financial results and changes to segment reporting. For example, an 8-K filing describes notable changes to Markel Group’s financial reporting, including the re-segmentation of its businesses and the expansion of consolidated and segment financial metrics, accompanied by a Reporting Changes Guide furnished as an exhibit.
The filings set also includes Form 10-Q references, where Markel Group discusses operating revenues, operating income, adjusted operating income, and segment performance for Markel Insurance, Industrial, Financial, and Consumer and Other. These documents provide detailed information on how the company measures performance over time and how its specialty insurance operations support the broader system of businesses and investments.
Investors may also encounter specialized filings such as Form 15 related to specific plans. In one case, a Form 15 filing for the Costa Farms, LLC 401(k) Plan explains the termination of an investment option linked to Markel Group common shares and clarifies that this suspension of the plan’s reporting obligations does not affect Markel Group Inc.’s duty to file reports for its common shares.
On Stock Titan, these filings are paired with AI-powered summaries designed to highlight the main points of each document. Users can quickly see which exhibits were furnished with an 8-K, how segment results are evolving in quarterly reports, and how non-GAAP measures such as adjusted operating income are defined and used by the company. This page is a resource for understanding Markel Group’s regulatory history, segment disclosures, and the financial context behind its specialty insurance and diversified business activities.
Markel Group Inc. (MKL) furnished an update on its 2025 third quarter and nine‑months results via a press release attached to an 8‑K. The company also outlined reporting changes, including a re‑segmentation of its businesses and expanded consolidated and segment metrics.
To help readers compare periods, Markel furnished supplemental recast quarterly financial information as Exhibit 99.2. A Reporting Changes Guide (Exhibit 99.3) explains the new structure and disclosures and is also available at ir.mklgroup.com. These materials are intended to clarify the company’s updated presentation alongside the latest quarterly results.
Markel Group Inc. reported third-quarter 2025 results. Total operating revenues were $3.934 billion, up from $3.694 billion a year ago, as earned premiums reached $2.206 billion and services and other revenues grew to $875.6 million. Operating income was $1.010 billion.
Profitability eased year over year. Net income to common shareholders was $751.3 million versus $905.0 million, with diluted EPS of $59.25 versus $66.25. Net investment gains were $432.9 million compared with $917.5 million last year, and foreign exchange moved to a $19.3 million gain from a $111.6 million loss. The company’s accumulated other comprehensive loss improved to $(138.97) million as unrealized losses narrowed.
Balance sheet and cash flow remained strong. Total assets were $67.39 billion and shareholders’ equity was $18.04 billion. Net cash provided by operating activities for the nine months was $2.099 billion. Year to date, the company redeemed $600 million of preferred stock and repurchased $344.0 million of common stock. Markel reorganized segments and, in August 2025, sold renewal rights for its Global Reinsurance division; premiums from prior multi‑year contracts will continue earning over the next two to three years.
Markel Group (MKL) reported insider activity by its CFO, Brian J. Costanzo. On September 30, 2025, he acquired 1.846 shares of common stock under the MKL 2020 Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3(c) at a price of $1,624.66 per share.
Following the transaction, Costanzo beneficially owned 976.0816 shares directly and 223.838 shares indirectly through the MKL 401(k) plan. The 401(k) plan balance reflects an additional 2.136 shares acquired between June 30, 2025 and September 30, 2025.
Meade P. Grandis, Chief Accounting Officer and Controller of Markel Group Inc. (MKL), reported a sale on 08/25/2025 of 75 shares of Markel common stock for $1,983.78 as shown on this Form 4. The filing lists multiple categories of beneficial ownership across trusts, retirement plan and family members, including entries labeled "By Trusts," a 401(k) plan balance, an irrevocable trust, and holdings attributed to spouse, daughter and son. Explanatory footnotes describe the spouse’s role as co-trustee and a distribution of 3,569.5 shares from the trusts to the spouse; plan share details reflect the 401(k) balance as of June 30, 2025. The form is signed by an attorney-in-fact on behalf of the reporting person.